Significance on Attack of COVID-19 in the Brain

Journal of Health & Medical Informatics

ISSN: 2157-7420

Open Access

Perspective - (2022) Volume 13, Issue 12

Significance on Attack of COVID-19 in the Brain

Reshma Khatoon*
*Correspondence: Reshma Khatoon, Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Korea, Email:
Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Korea

Received: 03-Dec-2022, Manuscript No. jhmi-23-88765; Editor assigned: 05-Dec-2022, Pre QC No. P-88765; Reviewed: 16-Dec-2022, QC No. Q-88765; Revised: 22-Dec-2022, Manuscript No. R-88765; Published: 30-Dec-2022 , DOI: 10.37421/2157-7420.2022.13.453
Citation: Khatoon, Reshma. “Significance on Attack of COVID-19 in the Brain.” J Health Med Informat 13 (2022): 453.
Copyright: © 2022 Khatoon R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


An abnormal immune response to a human coronavirus infection known as SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019 (COVID-19), a diverse and intricate condition. According to significant clinical findings in the areas of diagnosis, therapeutic management, and prevention, COVID-19 exhibits a wide range of severity, ranging from asymptomatic to fatal clinical outcomes. SARSCoV-2 primarily affects lung function during the acute phase of an infection by invading and reproducing in the upper respiratory tract before swiftly migrating to the lower respiratory tracts, where it can cause severe or fatal pneumonia. However, SARS-related CoV-2 effects on multiorgan systems are associated with a variety of long-lasting symptoms [1].


According to guidelines from the National Institute for Health and Care Excellence (NICE) and reports from the British Office for National Statistics (ONS), post-COVID-19 conditions in the aspiratory, cardiovascular, and sensory systems commonly referred to as long-COVID have been observed in more than 20% of individuals for a considerable amount of time following severe SARS-CoV-2 disease. The arrangements of transformations that result in variations of explicit contagiousness and antigenicity do not set in stone the high biodiversity or irresistible nature of the species. Five "variations of concern" (VoC) have been described by their irresistible potential, spread, and casualty rate in light of the subatomic design of SARS-CoV-2 and hereditary heterogeneity [2]. These properties are influenced by changes in viral underlying proteins like the spike protein (S), envelope (E), layer (M), nucleocapsid (N), and those that coordinate viral gathering and replication. In the field of viral science, the variety of these proteins determines viral pathogenicity, infectivity, and antigenicity due to the high rate of hereditary varieties. Researchers have been attempting to identify the entire component that enables the viral particles to enter and taint solid human cells ever since the beginning of the COVID-19 pandemic. Similar to other -COVIDS (-CoVs), SARS-CoV-2 utilizes the S protein to initiate collaboration between the viral capsid and the films of the host cell. The useful regions of S protein that recognize specific host receptors and intervene in the combination with have cell films are included in the systems that underpin the section into the host cells [3].

Through the intervention of host cell proteases such as Transmembrane Protease Serine 2 (TMPRSS2), furin, and cathepsins, the cleavage of S protein into S1 and S2 spaces marks the beginning of this cycle. The recognition and cooperation between the S1 subunit's Receptor-restricting Space (RBD) and the host receptors is dependent on proteolytic handling within the S1 subunit. The angiotensin-converting over protein 2 (ACE2) has been identified as the human cell section receptor for SARS-CoV-2 in clinical and exploratory studies. Depending on the host's age and natural sex, the declaration of the transmembrane, but not dissolvable, ACE2 isoform was significantly correlated with viral RNA load and TMPRSS2 articulation. Renin Angiotensin Framework (RAS) modulators, including Angiotensin Receptor Blockers (ARB), can also increase the risk of SARS-CoV-2 contamination and the progression of its replication, as demonstrated in refined Vero E6 cells [4].

Strong cell tropism and extensive articulation of ACE2 in a few body organs are responsible for the variation in illness severity following SARS-CoV-2 infection. As a result, there is a strong connection to moderate brokenness in the immune, respiratory, cardiovascular, and sensory systems. Nevertheless, there is growing evidence that highly sialylated cell glycoconjugates are present in the viral section, motor, and resistant guideline of SARS-CoV-2 infections. The connection with the host surface glycocalyx can be practically engaged with the rapid infectivity and spread in sialic corrosive rich organs because the underlying investigation of the SARS-CoV-2 N-terminal area (NTD) revealed the capacity of specific amino corrosive arrangements to frame sialoside restricting pockets. The role of sialic acids as regulators of SARS-CoV-2's infective potential and obtrusiveness was discovered during the primary investigation of human-CoVs as instruments of contamination, tropism, and pathogenesis [5].


The significance of sialic acids in the focal sensory system-related pathology caused by SARS-CoV-2 is the immediate focus of this audit. Utilizing the sialoglycans as an alternative viral sectioning tool, we investigate the relationship between COVID-19-induced changes in the human cell surface sialome and clinical conditions in the brain.


  1. Douaud, Gwenaëlle, Soojin Lee, Fidel Alfaro-Almagro and Christoph Arthofer. “SARS-CoV-2 is associated with changes in brain structure in UK Biobank.” Nature (2022): 1–17.
  2. Google Scholar, Crossref, Indexed at

  3. Lipton, P, and T S Whittingham. “The effect of hypoxia on evoked potentials in the invitro hippocampus.” J Physiol 287 (1979): 427–438.
  4. Google Scholar, Crossref 

  5. Nouri-Vaskeh, Masoud, Ali Sharifi, Neda Khalili and Ramin Zand. “Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism.” Clin Neurol Neurosurg 198 (2020): 106217.
  6. Google Scholar, Crossref, Indexed at

  7. Mukandala, Gatambwa, Ronan Tynan, Sinead Lanigan and John J O'Connor. “The effects of hypoxia and inflammation on synaptic signaling in the CNS.” Brain Sci 6(2016): 6.
  8. Google Scholar, Crossref, Indexed at

  9. Bocci, Matteo, Clara Oudenaarden, Xavier Sàenz-Sardà and Joel Simrén. “Infection of brain pericytes underlying neuropathology of COVID-19 patients.” Int J Mol Sci 22 (2021): 11622.
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 2128

Journal of Health & Medical Informatics received 2128 citations as per Google Scholar report

Journal of Health & Medical Informatics peer review process verified at publons

Indexed In

arrow_upward arrow_upward